All News
Verve gene-editing therapy lowers cholesterol without serious side effects in early study
Verve Therapeutics said Monday that initial data show that its investigational gene-editing therapy lowered cholesterol without inducing serious side effects.
Read MoreSunfox Technologies awarded the Startup Maharathi title at Startup Mahakumbh 2025
Union Minister of Commerce and Industry Piyush Goyal conferred this award to the cofounders of Sunfox
Read MorePfizer to discontinue its GLP-1 pill for obesity due to liver toxicity
Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity.
Read MoreCura Care raises ₹5 Cr in pre-seed funding led by Zeropearl VC
Cura Care aims to integrate oral wellness into the daily self-care routines of Indians by offering at-home dental services
Read MoreHigh levels of toxic chemicals found in paper receipts used by US retailers
Holding the receipts for 10 seconds absorbs enough bisphenol S to break California’s safety rule, research findsSign up for the Detox Your Kitchen newsletterPaper receipts from major retailers in th
Read MoreThis Kidney Was Frozen for 10 Days. Could Surgeons Transplant It?
Scientists developed a way to freeze a large mammal’s kidney, which could ease organ shortages in the future. First, they had to see if their method would work in a pig.
Read MoreMagic Happens When Kids and Adults Learn To Swim. Tragedy Can Strike if They Don’t.
A swim team in North St.
Read MoreFamilies of Transgender Youth No Longer View Colorado as a Haven for Gender-Affirming Care
Colorado was long considered a haven for gender-affirming care. But under this Trump administration, hospitals in the state have limited the treatments available for people under 19.
Read MoreThe silent pandemic: Antimicrobial resistance
Dr Farooq Ulla Khan, ICU Consultant, Mahaveer Jain Hospital, Bowring Hospital highlights that the consequences of AMR are dire.
Read MoreClosure of CDC hepatitis lab imperils U.S. outbreak response, prevention
The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s premier testing laboratory for viral hepatitis, experts warned.
Read More